货号:GS40580
Rademikibart is a human monoclonal antibody designed to selectively target and neutralize interleukin-4 receptor alpha (IL-4Rα). By blocking IL-4Rα, it inhibits signaling of both IL-4 and IL-13, key cytokines driving type 2 inflammation. It is being developed for the treatment of atopic dermatitis, asthma, and other allergic or eosinophilic diseases.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯